Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Increased Reslizumab Dosage for Severe Asthma
Recruiting3 awardsPhase 4
Hamilton, Ontario
This trial found that increasing the dose of reslizumab can help to reduce sputum eosinophilia in people with severe asthma who continue to have this problem despite treatment with reslizumab at the standard dose.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.